These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34970264)

  • 61. In vitro cultured peripheral blood mononuclear cells from patients with chronic schistosomiasis mansoni show immunomodulation of cyclin D1,2,3 in the presence of soluble egg antigens.
    Campi-Azevedo AC; Gazzinelli G; Bottazzi ME; Teixeira-Carvalho A; Corrêa-Oliveira R; Caldas IR
    Microbes Infect; 2007 Oct; 9(12-13):1493-9. PubMed ID: 17913547
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
    Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
    Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunological indicators of morbidity in human schistosomiasis mansoni: role of vascular endothelial growth factor and anti-soluble egg antigen IgG4 in disease progression.
    Tawfeek GM; Alafifi AM; Azmy MF
    J Egypt Soc Parasitol; 2003 Aug; 33(2):597-614. PubMed ID: 14964670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
    Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
    J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunological profiles of patients from endemic areas infected with Schistosoma mansoni.
    Gazzinelli G; Viana IR; Bahia-Oliveira LM; Silveira AM; Queiroz CC; Carvalho Odos S; Massara CL; Fraga LA; Colley DG; Correa-Oliveira R
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():139-42. PubMed ID: 1343884
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients.
    Silveira-Lemos D; Teixeira-Carvalho A; Martins-Filho OA; Alves Oliveira LF; Costa-Silva MF; Matoso LF; de Souza LJ; Gazzinelli A; Corrêa-Oliveira R
    Acta Trop; 2008; 108(2-3):150-9. PubMed ID: 18550021
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
    Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
    Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. III. In vitro granuloma modulation induced by immune complexes.
    Goes AM; Gazzinelli G; Rocha R; Katz N; Doughty BL
    Am J Trop Med Hyg; 1991 Apr; 44(4):434-43. PubMed ID: 1904197
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of Symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni.
    Brandt CT; Rino M; Pitta MG; Muniz JS; Silveira Dde O; Castro CM
    Rev Col Bras Cir; 2010 Oct; 37(5):333-7. PubMed ID: 21180998
    [TBL] [Abstract][Full Text] [Related]  

  • 70. T regulatory cell responses to immunization with a soluble egg antigen in Schistosoma mansoni-infected mice.
    El-Ahwany E; Bauiomy IR; Nagy F; Zalat R; Mahmoud O; Zada S
    Korean J Parasitol; 2012 Mar; 50(1):29-35. PubMed ID: 22451731
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multivariable Regression Analysis in Schistosoma mansoni-Infected Individuals in the Sudan Reveals Unique Immunoepidemiological Profiles in Uninfected, egg+ and Non-egg+ Infected Individuals.
    Elfaki TE; Arndts K; Wiszniewsky A; Ritter M; Goreish IA; Atti El Mekki Mel Y; Arriens S; Pfarr K; Fimmers R; Doenhoff M; Hoerauf A; Layland LE
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004629. PubMed ID: 27152725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens.
    Walter K; Fulford AJ; McBeath R; Joseph S; Jones FM; Kariuki HC; Mwatha JK; Kimani G; Kabatereine NB; Vennervald BJ; Ouma JH; Dunne DW
    J Immunol; 2006 Oct; 177(8):5490-8. PubMed ID: 17015735
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community.
    Naus CW; Booth M; Jones FM; Kemijumbi J; Vennervald BJ; Kariuki CH; Ouma JH; Kabatereine NB; Dunne DW
    Trop Med Int Health; 2003 Jun; 8(6):561-8. PubMed ID: 12791062
    [TBL] [Abstract][Full Text] [Related]  

  • 74. IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease.
    Fairfax KC; Amiel E; King IL; Freitas TC; Mohrs M; Pearce EJ
    PLoS Pathog; 2012 Jan; 8(1):e1002490. PubMed ID: 22291593
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nitric oxide interaction with IL-10, MIP-1alpha, MCP-1 and RANTES over the in vitro granuloma formation against different Schistosoma mansoni antigenic preparations on human schistosomiasis.
    Oliveira DM; Silva-Teixeira DN; Gustavson S; Oliveira SM; Goes AM
    Parasitology; 2000 Apr; 120 ( Pt 4)():391-8. PubMed ID: 10811280
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of Schistosoma mansoni 44.7/56.8 kDa egg antigens recognized by human monoclonal antibodies which induce protection against experimental infection and proliferation of peripheral blood mononuclear cells from schistosomiasis patients.
    Hirsch C; Almeida CA; Doughty BL; Goes AM
    Vaccine; 1997 Jun; 15(9):948-54. PubMed ID: 9261940
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters.
    Verwaerde C; Thiam K; Delanoye A; Fernandez-Gomez R; D'Halluin J; Auriault C
    Eur Cytokine Netw; 1999 Jun; 10(2):161-70. PubMed ID: 10400822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human giant cell formation induced in vitro by Schistosoma mansoni antigens.
    Silva-Teixeira DN; Ferreira MG; Nogueira-Machado JA; Doughty BL; Goes AM
    Braz J Med Biol Res; 1993 Jun; 26(6):609-13. PubMed ID: 8257946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of Schistosoma mansoni specific human T-T hybrids.
    Contigli C; Carmo SA; Goes AM
    Hybridoma; 1998 Oct; 17(5):421-9. PubMed ID: 9873987
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protective role of IL-22 against Schistosoma mansoni soluble egg antigen-induced granuloma in Vitro.
    Nady S; Shata MT; Mohey MA; El-Shorbagy A
    Parasite Immunol; 2017 Jan; 39(1):. PubMed ID: 27741351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.